Journal of Gynecologic Oncology

Article	Citations
Increased cardiovascular disease risk among adolescent and young adult survivors of cervical cancer	106
Practice guideline for management of endometrial cancer in Thailand: a Thai Gynecologic Cancer Society consensus statement	43
Para-aortic lymph node dissection with or without nerve-sparing in gynecological malignancies	38
Missing a chance to prevent: disparities in completion of genetic evaluation in high-risk patients with endometrial cancer	34
Developing standardized informed consent for hysterectomy and vulva cancer surgery	32
Pregnancy complications and outcomes in patients with early endometrial cancer or atypical hyperplasia after fertility-sparing treatment	28
Evaluation of secondary cytoreduction surgery in platinum-resistant ovarian cancer patients within three-line recurrent: a multicenter, randomized controlled study	26
Nomogram for predicting pathology upstaging in patients with EIN: is sentinel lymph node assessment useful in these patients?	26
Impact of adjuvant chemotherapy on the overall survival of patients with resectable bulky small cell neuroendocrine cervical cancer: a JSGO-JSOG joint study	24
The efficacy of the levonorgestrel intrauterine system versus oral megestrol acetate in treating atypical endometrial hyperplasia: a superior randomized controlled trial	24
Circ_0075960 targets the miR-202-5p/CTNND1 axis to promote the growth and migration of endometrial carcinoma cells via regulating Wnt/β-catenin signaling activity	23
Laparoscopic radical hysterectomy without uterine manipulator or vaginal tube use	21
Prognostic influence of an early time to chemotherapy following primary cytoreductive surgery for advanced epithelial ovarian cancer	19
Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey	18
Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and over	18
Fertility-sparing treatment outcomes using immune checkpoint inhibitors in endometrial cancer patients with Lynch syndrome	17
Evaluation of the role of liver metastasectomy in the treatment of stage IV endometrial cancer	17
The 7th Biennial Meeting of the Asian Society of Gynecologic Oncology, November 25th to 27th, 2021	17
Elucidation of genomic origin of synchronous endometrial and ovarian cancer (SEO) by genomic and microsatellite analysis	16
Efficacy of edoxaban for the treatment of gynecological cancer-associated venous thromboembolism: analysis of Japanese real-world data	16
Functions, interactions and prognostic role of POLE: a bioinformatics analysis	15
Salvage hysterectomy for persistent residual cervical cancer: assessment of prognostic factors	15
Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review	14
Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective,	14
Genomic landscape of advanced endometrial cancer analyzed by targeted next-generation sequencing and the cancer genome atlas (TCGA) dataset	14

Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy	14
Current peritonectomy practice during debulking surgery in patients with newly diagnosed advanced ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 4004)	14
Immunotherapy plus chemotherapy in patients with advanced endometrial cancer: a cost-effectiveness analysis	13
Diagnostic accuracy and prognostic factors of uterine serous carcinoma in Japanese women: a multi-center study	13
A multimodal intervention program to improve sexual health and self-perceived quality of life in patients treated for cervical cancer: a randomized prospective study (PROVIDENCE trial)	13
Risk of CIN2+ in women aged >60 years with abnormal cervical cancer screening: a multicenter retrospective cohort study from the Thai Gynecologic Cancer Society research group	13
Olaparib plus bevacizumab as a first-line maintenance treatment for patients with advanced ovarian cancer by molecular status: an updated PAOLA-1 based cost-effectiveness analysis	12
Prognostic significance of heterologous component in carcinosarcoma of the gynecologic organs: a systematic review and meta-analysis	12
Clinical evaluation of a droplet digital PCR assay for detecting POLE mutations and molecular classification of endometrial cancer	12
Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial)	11
Cervical screening among Chinese females in the era of HPV vaccination: a population-based survey on screening uptake and regular screening following an 18-year organized screening program	11
Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage epithelial ovarian cancer in Australia, South Korea and Taiwan	11
Supragastric lesser sac: an insidious site for surgical exploration during the debulking surgery in advanced ovarian cancer	11
Enrichment for the POLE mutated against p53 wild subtype using clinicopathologic factors and cyclin B1 immunohistochemistry in endometrial cancer	11
East Asian Gynecologic Oncology Trial Group (EAGOT): founding history and future perspective	10
A step towards the ambition of precision oncology in recurrent ovarian cancer	10
Real-world efficacy and safety of bevacizumab single-maintenance therapy following platinum-paclitaxel chemotherapy plus bevacizumab in patients with advanced cervical cancer	10
RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma	10
Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multice	10
Clinical implications of the superficial uterine vein pattern for the dissection of the anterior layer of the vesicouterine ligament in radical hysterectomy	9
Differentiation of uterine fibroids and sarcomas by MRI and serum LDH levels: a multicenter study of the KAMOGAWA study	9
Implementation rate and related factors of confirmatory tests following an abnormal Pap smear: a nationwide study from the National Health Insurance	9
HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma	9
A prospective comparison of the diagnostic accuracies of ultrasound and magnetic resonance imaging in preoperative staging of endometrial cancer	9
Cost-effectiveness analysis of hospital treatment volume and survival outcomes in endometrial cancer in Japan	8
Incidence and risk factors for the development of cerebral metastasis in cervical cancer patients	8
Identification of the prognostic immune subtype in copy-number high endometrial cancer	8
Significance of histology and nodal status on the survival of women with early-stage cervical cancer: validation of the 2018 FIGO cervical cancer staging system	8
Development and validation of a prognostic model based on metabolic risk score to predict overall survival of endometrial cancer in Chinese patients	8
Cost-effectiveness of atezolizumab plus chemotherapy for advanced/recurrent endometrial cancer	8
Adjuvant pelvic radiation versus observation in intermediate-risk early-stage cervical cancer patients following primary radical surgery: a propensity score-adjusted analysis	8
Transabdominal cardiophrenic lymph node dissection for cytoreductive surgery in advanced ovarian cancer	8
Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapy	7
Confirmation of the utility of the CA-125 elimination rate (KELIM) as an indicator of the chemosensitivity in advanced-stage ovarian cancer in a “real-life setting”	7
Preoperative serum microRNAs as potential prognostic biomarkers in ovarian clear cell carcinoma	7
Evaluation of clinical usefulness of HPV-16 and HPV-18 genotyping for cervical cancer screening	7
Adjuvant carboplatin and paclitaxel with “sandwich” method radiotherapy for stage III or IV endometrial cancer: long-term follow-up at a single-institution	7
Emergency craniotomy: a life-saving procedure as part of multi-modal therapy of GTN	7
Reviewer recognition in 2024	7
The sealing effect of magnetic-sealing uterine manipulator in isolated uterus from patients with early-stage cervical cancer: a pre-clinical study	7
Intra- and postoperative complications associated with diaphragmatic surgery for advanced ovarian cancer	7
Humanized patient-derived xenograft mouse model bearing ovarian clear cell carcinoma	7
Bevacizumab combined with chemotherapy could be superior to chemotherapy alone in relapsed ovarian cancer after PARPi: evidence from a multi-center propensity score-matched analysis	7
Development of a prognostic prediction support system for cervical intraepithelial neoplasia using artificial intelligence-based diagnosis	7
Efficacy of fertility-sparing treatment with LNG-IUS is associated with different ProMisE subtypes of endometrial carcinoma or atypical endometrial hyperplasia	6
Prognostic value of complete metabolic response on 18F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer	6
RAIDS atlas of significant genetic and protein biomarkers in cervical cancer	6
Cancer-field surgery for endometrial cancer by robotic peritoneal mesometrial resection and targeted compartmental lymphadenectomy (PMMR+TCL)	6
Th2 cells infiltrating high-grade serous ovarian cancer: a feature that may account for the poor prognosis	6
LncRNA linc01194 promotes the progress of endometrial carcinoma by up-regulating SOX2 through binding to IGF2BP1	6

Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from MITO-MaNGO Groups	6
The value of PET/CT for cytoreductive surgery selection in recurrent ovarian carcinoma	6
The SHAPE trial: is good is good enough?	6
Comparison of carboplatin-based chemotherapy versus cisplatin-based chemotherapy in the treatment of malignant gonadal germ cell tumor: a systematic review and meta-analysis	6
A phase II trial evaluating the efficacy and safety of repeated high dose medroxyprogesterone acetate (MPA) therapy for patients with recurrent early-stage endometrial cancer or atypical endometrial h	6
Evolving standards and future directions for systemic therapies in cervical cancer	6
Alternative splicing of PSMD13 mediated by genetic variants is significantly associated with endometrial cancer risk	6
Platinum free interval and clinical benefit of the second-line chemotherapy in recurrent uterine and ovarian carcinosarcoma: a retrospective cohort analysis	6
Can surgery boost the survival benefit of chemoradiotherapy in T1b1-T2a1 stage cervical cancer with lymph node metastasis? A population-based study	6
Asian Society of Gynecologic Oncology (ASGO) 2024 Annual Meeting in Bali, Indonesia	6
Effectiveness of craniotomy and long-term survival in 35 patients with gestational trophoblastic neoplasia with brain metastases: a clinical retrospective analysis	5
The pathologic and clinical outcomes of risk-reducing salpingo-oophorectomy in asymptomatic carriers of homologous recombination repair gene mutation	5
Validation of HPV triage in cytology-based cervical cancer screening for ASC-US cases using Japanese data	5
Comparison of progression-free survival outcome of sentinel node biopsy without ultrastaging versus lymphadenectomy in endometrial cancer: a propensity-matched analysis	5
Minimally invasive radical hysterectomy and the importance of avoiding cancer cell spillage for early-stage cervical cancer: a narrative review	5
Revisiting the meaning of Trousseau sign and syndrome	5
CircSMAD2 accelerates endometrial cancer cell proliferation and metastasis by regulating the miR-1277-5p/MFGE8 axis	5
Clinical practice guidelines for cervical cancer: an update of the Korean Society of Gynecologic Oncology Guidelines	5
Protective ostomies in ovarian cancer surgery: a systematic review and meta-analysis	5
Cause-specific mortality rate of ovarian cancer in the presence of competing risks of death: a nationwide population-based cohort study	5
Rotational intraperitoneal pressurized aerosol chemotherapy with paclitaxel and cisplatin: pharmacokinetics, tissue concentrations, and toxicities in a pig model	5
Improved bladder function in radical hysterectomy without worsening oncologic outcome: resection of the posterior layer of the vesicouterine ligament with the procedure limited to the vesical veins	5
Bispecific immunotherapy MEDI5752 or volrustomig and cervical cancer	5
The 8th Biennial Meeting of the Asian Society of Gynecologic Oncology, December 1st to 3rd, 2023	5
Sentinel node mapping in endometrial cancer	5
Effect of adjuvant treatment on survival in 2023 FIGO stage IIC endometrial cancer	5
Incidence and treatment outcomes of uterine cervical cancer in Korea 1999–2018 from the national cancer registry	5
Diagnostic significance and predictive efficiency of metabolic risk score for fertility-sparing treatment in patients with atypical endometrial hyperplasia and early endometrial carcinoma	5
Missing a chance to prevent: disparities in completion of genetic evaluation in high-risk patients with endometrial cancer	4
Cost-effectiveness of pembrolizumab plus chemotherapy for advanced endometrial cancer	4
The course forward: next generation sequencing as part of the next generation management of patients with locally advanced cervical cancer	4
Prognostic values of tumor size and location in early stage endometrial cancer patients who received radiotherapy	4
Clinicopathologic and protein markers distinguishing the “polymerase epsilon exonuclease” from the “copy number low” subtype of endometrial cancer	4
Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the Gynecologic Oncology Committee of the Japan Society of O	4
Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: an	4
Abnormal p53 expression is associated with poor outcomes in grade I or II, stage I, endometrioid carcinoma: a retrospective single-institute study	4
TP53 variants in p53 signatures and the clonality of STICs in RRSO samples	4
Comparison of the safety between cervical conization and hysterectomy for patients with cervical adenocarcinoma in situ	4
Prevention of symptomatic pulmonary embolism for gynecologic malignancies with preoperative asymptomatic venous thromboembolism: GOTIC-VTE trial	4
Impact of COVID-19 on gynecologic cancer treatment in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)	4
Molecular classification of endometrial cancer: entering an era of precision medicine	4
A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Onco	4
Prevalence and prognostic value of PD-L1 expression and tumor mutational burden in persistent, recurrent, or metastatic cervical cancer	4
Mutations in homologous recombination repair genes in patients with metastatic endometrial cancer: association with clinical characteristics and prognosis	4
Targeting BRAF pathway in low-grade serous ovarian cancer	4
Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications	4
Gut microbiome associated with PARP inhibitor efficacy in patients with ovarian cancer	3
Intraoperative frozen pathology exam of Common iliac lymph nodes and Para-Aortic lymphadenectomy on the prognosis and quality of life for patients with IB2-IIA2 Cervical Cancer: trial protocol for a r	3
Oncologic outcomes according to the level of disease burden in patients with metachronous distant metastases from uterine cervical cancer: a Korean Radiation Oncology Group study (KROG 18-10)	3
Clinical trial comparing the use of Orcellex® Brush versus Cervex-Brush® on vaginal vault smear cytology adequacy rate in patients treated with radiotherapy for cervical cancer	3
ASGO 7th International Workshop on Gynecologic Oncology	3
FIGO staging of endometrial cancer: 2023	3
Randomized comparison between sentinel lymph node mapping using indocyanine green plus a fluorescent camera versus lymph node dissection in clinical stage I-II endometrial cancer: a Korean Gynecologic	3
HPV vaccination status and effectiveness in Korean women with HPV16/18 infection (2010–2021): a retrospective study	3
Clinical characteristics and status of treatment of small-cell carcinoma of the ovary, hypercalcemic type in the Chinese population: a meta-analysis	3
Current treatment strategies for ovarian cancer in the East Asian Gynecologic Oncology Trial Group (EAGOT)	3
Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics	3
Radical hysterectomy or chemoradiotherapy for clinically early-stage cervical cancer with suspicious lymph nodes on imaging: a retrospective cohort study	3
International cost-effectiveness analysis of chemoradiotherapy plus pembrolizumab for locally advanced cervical cancer	3
Different surgical methods for FIGO stage IVB cervical cancer patients receiving chemotherapy: a population-based study	3
Expert commentary on HORSE/MITO18 and CHIPOR	3
A predictive model for lymph node metastasis using tumor location in presumed early-stage endometrioid endometrial cancer patients	3
Role of adjuvant chemotherapy in stage IC ovarian granulosa cell tumors: a systematic review and meta-analysis	3
Cisplatin-induced PANDAR-Chemo-EVs contribute to a more aggressive and chemoresistant ovarian cancer phenotype through the SRSF9-SIRT4/SIRT6 axis	3
Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience	3
Impact of adjuvant treatment on survival in patients with 2023 FIGO stage IIC endometrial cancer: a retrospective analysis from two tertiary centers in Korea and Taiwan	3
PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia	3
Prognostic factors of dose-response relationship for nodal control in metastatic lymph nodes of cervical cancer patients undergoing definitive radiotherapy with concurrent chemotherapy	3
Erratum: Recent breakthroughs in the management of locally advanced and recurrent/metastatic cervical cancer	3
Efficacy and prognosis of robotic surgery with sentinel node navigation surgery in endometrial cancer	3
Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial	3
Circular RNA intraflagellar transport 80 facilitates endometrial cancer progression through modulating miR-545-3p/FAM98A signaling	3
RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study	3
Knowledge and awareness of cervical cancer and prevention measures among female students in Poland: a cross-sectional, decade apart study	3
TET3-mediated DNA demethylation modification activates SHP2 expression to promote endometrial cancer progression through the EGFR/ERK pathway	3
Modified posterior pelvic exenteration combined with ileocecal resection for locally advanced endometrial cancer	3
Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer	3
Poor accuracy of endometrial sampling in patients with uterine carcinosarcomas: a nationwide analysis	3
An overview of the current debate between using minimally invasive surgery versus laparotomy for interval cytoreductive surgery in epithelial ovarian cancer	3
Interleukin-34 cancels anti-tumor immunity by PARP inhibitor	3

Evaluating the specific STAT3 inhibitor YHO-1701 in ovarian cancer cell lines and patient-derived cell models: efficacy, mechanisms, and therapeutic potential	2
Is it time to change surgery for early-stage low-risk cervical cancer to simple hysterectomy?	2
Selective utilization of circulating tumor DNA testing enables disease monitoring in endometrial and ovarian carcinomas	2
LncRNA STARD7-AS1 suppresses cervical cancer cell proliferation while promoting autophagy by regulating miR-31-5p/TXNIP axis to inactivate the mTOR signaling	2
The prognosis impact of NACT-IDS and PDS in advanced ovarian cancer: a systematic review and meta-analysis	2
Book Review: IARC handbooks of cancer prevention, volume 18: Cervical cancer screening	2
SLAMF7 predicts prognosis and correlates with immune infiltration in serous ovarian carcinoma	2
The prognostic significance of primary tumor site in vulvar cancer: a population-based cohort study	2
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician’s choice chemotherapy in patients with previously treated advanced or recurrent end	2
Ovarian squamous cell carcinoma: clinicopathological features, prognosis and immunotherapy outcomes	2
Diagnostic performances of the Ovarian Adnexal Reporting and Data System, the Risk of Ovarian Malignancy Algorithm, and the Copenhagen Index in the preoperative prediction of ovarian cancer: a prospec	2
Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology consensus statement	2
HIPEC in recurrent ovarian cancer: flogging a tired HORSE?	2
AP2α negatively regulates PDHA1 in cervical cancer cells to promote aggressive features and aerobic glycolysis in vitro and in vivo	2
Integrated analysis of DNA methylome and transcriptome reveals SFRP1 and LIPG as potential drivers of ovarian cancer metastasis	2
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer	2
Genetic analysis of cervical cancer with lymph node metastasis	2
Quality indicators for endometrial cancer care in Japan	2
Clinical practice guidelines for ovarian cancer: an update to the Korean Society of Gynecologic Oncology guidelines	2
Impact of peritoneal vaginoplasty combined with radical hysterectomy on the quality of sexual life for patients with early-stage cervical cancer: trial protocol for a multi-center superiority randomiz	2
Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting	2
Planning and performing simultaneous bariatric surgery and robotic hysterectomy in a super-obese patient with endometrial cancer	2
Novel vaginoplasty technique involving the use of peritoneal flaps during laparoscopic radical hysterectomy for early-stage cervical cancer	2
Airborne and surface contamination after rotational intraperitoneal pressurized aerosol chemotherapy using cisplatin	2
Correspondence on: The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter by Nicolai et al.	2
Closing the gap for cervical cancer research in Vietnam: current perspectives and future opportunities: a report from the 5th Gynecologic Cancer InterGroup (GCIG) Cervical Cancer Research Network (CCR	2
Efficacy of intra-abdominal cytoreductive surgery in advanced endometrial cancer with distant metastasis	2
Anti-cancer effect of fenbendazole-incorporated PLGA nanoparticles in ovarian cancer	2
ATF1 regulates MAL2 expression through inhibition of miR-630 to mediate the EMT process that promotes cervical cancer cell development and metastasis	2
Predictors of postoperative pancreatic fistula after splenectomy with or without distal pancreatectomy performed as a component of cytoreductive surgery for advanced ovarian cancer	2
Simple hysterectomy SHAPE-ing up to be the treatment of choice for early cervical cancer under 2 cm	2
Where is ERAS in the management of advanced ovarian cancer?: between myths and truths	2
Immunonutrition in ovarian cancer: clinical and immunological impact?	2
Reviewer recognition in 2022	2
Evaluation of autophagy related ATG4B gene, protein and miR-655-3p expression levels in endometrial cancer and hyperplasia	2
Revision of quality indicators for cervical cancer and trend analysis of existing indicators in Japan	2
Retraction: Circ_0075960 targets the miR-202-5p/CTNND1 axis to promote the growth and migration of endometrial carcinoma cells via regulating Wnt/β-catenin signaling activity	2
Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome	2
Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)	2
Clinical outcome and pattern of care for isolated or incidental serous tubal intraepithelial carcinoma: a multicenter retrospective cohort study	2
Prognostic factors of adult granulosa cell tumors of the ovary: a Turkish retrospective multicenter study	2
Management for perioperative complications of diaphragmatic surgery in ovarian cancer at a Chinese tertiary cancer center	1
Laparoscopic resection surgery for malignant transformation of extragonadal endometriosis by the “pincer” approach	1
Unveiling pembrolizumab effectiveness in diverse subtypes of MSI-high endometrial cancers	1
The 1st annual meeting of the East Asian Gynecologic Oncology Trial Group (EAGOT)	1
The added value of SLN mapping with indocyanine green in low- and intermediate-risk endometrial cancer management: a systematic review and meta-analysis	1
Japan Society of Gynecologic Oncology 2023 guidelines for treatment of uterine body neoplasm	1
Efficacy and safety of 3-dimensional printing noncoplanar template (3D-PNCT)-assisted high-dose-rate interstitial brachytherapy (HDR-ISBT) for reirradiation of recurrent cervical cancer: a prospective	1
Author's reply to: Cisplatin versus carboplatin?	1
Prognostic impact of peritoneal cytology on treating endometrial cancer using data from the Japan Society of Obstetrics and Gynecology cancer registry	1
Comparison of postoperative adjuvant platinum-based chemotherapy and no further therapy after radical surgery in intermediate-risk early-stage cervical cancer	1
Factors predicting postoperative morbidity after cytoreductive surgery for ovarian cancer: a systematic review and meta-analysis	1
The value of surgery and the prognostic factors for patients with recurrent low-grade endometrial stromal sarcoma: a retrospective study of 38 patients	1
Prognostic impact of the number of resected pelvic nodes in endometrial cancer: Japanese Gynecologic Oncology Group Study JGOG2043 post hoc analysis	1
Oncologic outcome of metachronous oligometastatic recurrence in advanced cervical cancer patients after primary radio-chemotherapy	1
Effectiveness and safety of nab-paclitaxel and platinum as first-line chemotherapy for ovarian cancer: a retrospective study	1
Anticancer effect of the antipsychotic agent penfluridol on epithelial ovarian cancer	1
Significance of HPV status on tumor response and treatment outcomes in endocervical adenocarcinoma treated with definitive chemoradiotherapy: a retrospective study	1
Accuracy of human papillomavirus tests on self-collected urine versus clinician-collected samples for the detection of cervical precancer: a systematic review and meta-analysis	1
Investigation of selective glucocorticoid receptor modulation in high-grade serous ovarian cancer PDX models	1
Adjuvant chemotherapy after radical hysterectomy yields comparable outcomes to chemoradiation for stage IB2-IIB and IIIC1-2 cervical cancer: a single-center retrospective study	1
Low-grade endometrial stromal sarcoma with intravenous thrombus extension: a multidisciplinary surgical challenge	1
Conditional relative survival of patients with endometrial cancer: a Korean National Cancer Registry study	1
Response to: Author's reply to: Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002)	1
Oncological safety of minimally invasive surgery in borderline ovarian tumor and ovarian cancer: a retrospective comparative study	1
Attitudes toward subsequent primary cancer prevention among survivors of childhood, adolescent, and young adult (CAYA) cancer in Japan: results of a comprehensive questionnaire survey on long-term wom	1
Author's reply to: Revisiting the meaning of Trousseau sign and syndrome	1
First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial	1
Toripalimab combined with bevacizumab plus chemotherapy as first-line treatment for refractory recurrent or metastatic cervical cancer: a single-arm, open-label, phase II study (JS001-ISS-CO214)	1
Application value of personalized 3D printing vaginal model for the Image-guided adaptive brachytherapy of cervical cancer	1
An evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva	1
Effect of quality control program on surgical management in advanced ovarian cancer	1
An update of oncologic and obstetric outcomes after abdominal trachelectomy using the FIGO 2018 staging system for cervical cancer: a single-institution retrospective analysis	1
Early prediction and risk stratification of ovarian cancer based on clinical data using machine learning approaches	1
Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines	1
FOLR1 as a therapeutic target in platinum-resistant ovarian carcinoma: unique expression patterns across ovarian carcinoma histotypes and molecular subtypes of low-grade serous carcinoma	1
One-step nucleic acid amplification (OSNA) assay for detecting lymph node metastasis in cervical and endometrial cancer: a preliminary study	1
Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study	1
Clinicopathological features and patterns of treatment of patients with endometrial cancer in Brazil	1
Epidemiologic characteristics and a prognostic nomogram for patients with vulvar cancer: results from the Surveillance, Epidemiology, and End Results (SEER) program in the United States, 1975 to 2016	1
Lymphocyte activation gene (LAG)-3 is a potential immunotherapeutic target for microsatellite stable, programmed death-ligand 1 (PD-L1)-positive endometrioid endometrial cancer	1
Diagnostic performance of microRNA-34a, let-7f and microRNA-31 in epithelial ovarian cancer prediction	1
Combined laparoscopic and transperineal endoscopic total pelvic exenteration for the vaginal stump recurrence of cervical cancer	1
Pembrolizumab plus chemotherapy with or without bevacizumab in East Asian participants with persistent, recurrent, or metastatic cervical cancer: results from KEYNOTE-826 final analysis	1
Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3	1
Feasibility, accuracy and acceptability of self-sampled human papillomavirus testing using careHPV in Cambodia: a cross-sectional study	1
Transvaginal cervical tumor-concealing no-look no-touch technique in minimally invasive radical hysterectomy for early-stage cervical cancer: a novel operation technique	1
Asian Young Doctors Session at the 64th Annual Meeting of the Japanese Society for Gynecologic Oncology (JSGO): Educational Initiatives in the Next Generation for a New Era after the COVID-19 Pandemic	1
Cisplatin versus carboplatin?	1
Comparison of immediate germline sequencing and multi-step screening for Lynch syndrome detection in high-risk endometrial and colorectal cancer patients	1
Study of neoadjuvant chemotherapy in advanced malignant ovarian germ cell tumors at a tertiary center in western India	1
Prevalence of high-risk human papillomavirus genotypes among women in Uzbekistan, 2021–2023	1
Epidemiologic study on gestational trophoblastic diseases in Japan	1
Regularity of cervical cancer screening in Korea: analysis using national public data for 12 years	1
Modifying surgical extents in patients with preoperatively presumed early-stage endometrial cancer based on ProMisE classification: a retrospective, single-center study	1